{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T15:22:59Z","timestamp":1777648979544,"version":"3.51.4"},"reference-count":30,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2011,4,1]],"date-time":"2011-04-01T00:00:00Z","timestamp":1301616000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,4,1]],"date-time":"2011-04-01T00:00:00Z","timestamp":1301616000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2011,4,1]],"date-time":"2011-04-01T00:00:00Z","timestamp":1301616000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2011,4,1]],"date-time":"2011-04-01T00:00:00Z","timestamp":1301616000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2011,4,1]],"date-time":"2011-04-01T00:00:00Z","timestamp":1301616000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2011,4,1]],"date-time":"2011-04-01T00:00:00Z","timestamp":1301616000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2011,4,1]],"date-time":"2011-04-01T00:00:00Z","timestamp":1301616000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","contraceptionjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Contraception"],"published-print":{"date-parts":[[2011,4]]},"DOI":"10.1016\/j.contraception.2010.08.009","type":"journal-article","created":{"date-parts":[[2010,10,4]],"date-time":"2010-10-04T04:28:44Z","timestamp":1286166524000},"page":"322-329","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Introduction and provision of medical abortion: a tale of two countries in which technology is necessary but not sufficient"],"prefix":"10.1016","volume":"83","author":[{"given":"Beverly","family":"Winikoff","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Danielle","family":"Hassoun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hillary","family":"Bracken","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3 Suppl","key":"10.1016\/j.contraception.2010.08.009_bb0005","article-title":"The development of Mif\u00e9pristone: a pharmaceutical drama in three acts","volume":"55","author":"Ulmann","year":"2000","journal-title":"J Am Med Women's Assn"},{"key":"10.1016\/j.contraception.2010.08.009_bb0010","article-title":"L'Interruption Volontaire de grossesse m\u00e9dicamenteuse","author":"Faucher","year":"2005","journal-title":"Estem"},{"key":"10.1016\/j.contraception.2010.08.009_bb0015","unstructured":"ANAES. Mars 2001.Recommandations pour la pratique clinique. Prise en charge de l'interruption volontaire de grossesse jusqu'\u00e0 14 semaines."},{"key":"10.1016\/j.contraception.2010.08.009_bb0020","unstructured":"Vilain A. Les interruptions volontaires de grossesse en 2007. DRESS. Etudes et r\u00e9sultats No 713. December 2009."},{"key":"10.1016\/j.contraception.2010.08.009_bb0025","unstructured":"Blayo C, Bourmeau A, Bureau A et al. 1992 Juin. Rapport sur la pratique de l'I.V.G. en France. Paris: Secr\u00e9tariat d'\u00c9tat aux droits des femmes et \u00e0 la consommation. ANCIC-INED."},{"key":"10.1016\/j.contraception.2010.08.009_bb0030","series-title":"L'IVG en France. Propositions pour diminuer les difficult\u00e9s que rencontrent les femmes","author":"Nisand","year":"1999"},{"key":"10.1016\/j.contraception.2010.08.009_bb0035","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1363\/4000608","article-title":"Abortion in the United States: incidence and access to services, 2005","volume":"40","author":"Jones","year":"2008","journal-title":"Perspect Sex Reprod Health"},{"key":"10.1016\/j.contraception.2010.08.009_bb0040","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1056\/NEJM198612183152501","article-title":"Termination of early pregnancy by the progesterone antagonist RU 486 (Mifepristone)","volume":"315","author":"Couzinet","year":"1986","journal-title":"N Engl J Med"},{"key":"10.1016\/j.contraception.2010.08.009_bb0045","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1056\/NEJM198612183152509","article-title":"Progesterone antagonism: science and society","volume":"315","author":"Crowley","year":"1986","journal-title":"N Engl J Med"},{"key":"10.1016\/j.contraception.2010.08.009_bb0050","first-page":"C1","article-title":"Conception of a controversy: the French doctor and his Pill to prevent pregnancy","author":"Rosenfeld","year":"1986","journal-title":"The Washington Post"},{"key":"10.1016\/j.contraception.2010.08.009_bb0055","first-page":"A1","article-title":"Drug maker stops all distribution of abortion pill","author":"Greenhouse","year":"1988","journal-title":"The New York Times"},{"key":"10.1016\/j.contraception.2010.08.009_bb0065","first-page":"A16","article-title":"AMA supports testing of French abortion pill","year":"1990","journal-title":"The New York Times"},{"key":"10.1016\/j.contraception.2010.08.009_bb0070","first-page":"A21","article-title":"U.S. defends border seizure of abortion pills","author":"Hilts","year":"1992","journal-title":"The New York Times"},{"key":"10.1016\/j.contraception.2010.08.009_bb0075","unstructured":"Benten v. Kessler, slip op. at 12, No. CV-92-3161 (E.D.N.Y. July 14, 1992) cited in NARAL. Mifepristone and the impact of abortion politics on scientific research and women's health. Cited on 15 June 2005. Available at http:\/\/www.naral.org\/Issues\/science\/science_fs.cfm."},{"key":"10.1016\/j.contraception.2010.08.009_bb0085","first-page":"A17","article-title":"Broader uses seen for abortion pill","author":"Leary","year":"1993","journal-title":"The New York Times"},{"key":"10.1016\/j.contraception.2010.08.009_bb0090","first-page":"43","article-title":"Many women eager to test abortion pill","year":"1994","journal-title":"The New York Times"},{"key":"10.1016\/j.contraception.2010.08.009_bb0095","first-page":"A21","article-title":"Group intensifies campaign to market abortion pill","author":"Lewin","year":"1997","journal-title":"The New York Times"},{"key":"10.1016\/j.contraception.2010.08.009_bb0100","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1001\/jama.1994.03520150058037","article-title":"Methotrexate and misoprostol vs. misoprostol alone for early abortion, a randomized controlled trial","volume":"272","author":"Creinin","year":"1994","journal-title":"JAMA"},{"key":"10.1016\/j.contraception.2010.08.009_bb0105","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1056\/NEJM199508313330901","article-title":"Methotrexate and misoprostol for induced abortion","volume":"333","author":"Hausknecht","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1016\/j.contraception.2010.08.009_bb0110","first-page":"198","article-title":"Methotrexate and misoprostol for early abortion","volume":"28","author":"Schaff","year":"1996","journal-title":"Fam Med"},{"key":"10.1016\/j.contraception.2010.08.009_bb0115","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1056\/NEJM199408043310502","article-title":"A comparison of intravaginal misoprostol with prostaglandin E2 for termination of second-trimester pregnancy","volume":"33","author":"Jain","year":"1994","journal-title":"N Engl J Med"},{"key":"10.1016\/j.contraception.2010.08.009_bb0120","first-page":"353","article-title":"Vaginal misoprostol administered after mifepristone (RU486) for abortion","volume":"44","author":"Schaff","year":"1997","journal-title":"J Fam Pract"},{"key":"10.1016\/j.contraception.2010.08.009_bb0125","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/0010-7824(93)90079-M","article-title":"Methotrexate and misoprostol for early abortion","volume":"48","author":"Creinin","year":"1993","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2010.08.009_bb0135","series-title":"Facts in Brief: Induced Abortion in the United States","author":"Alan Guttmacher Institute","year":"2005"},{"key":"10.1016\/j.contraception.2010.08.009_bb0140","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/S0010-7824(03)00049-0","article-title":"Mifepristone and misoprostol for early medical abortion: 18 months experience in the United States","volume":"67","author":"Hausknecht","year":"2003","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2010.08.009_bb0145","unstructured":"Personal communication, Danco Laboratories."},{"key":"10.1016\/j.contraception.2010.08.009_bb0150","article-title":"Planned parenthood medication abortion updates","author":"Fjerstad","year":"2005"},{"issue":"3","key":"10.1016\/j.contraception.2010.08.009_bb0155","doi-asserted-by":"crossref","first-page":"62330","DOI":"10.1097\/AOG.0b013e3181b2a74d","article-title":"Effect of mifepristone on abortion access in the United States","volume":"114","author":"Finer","year":"2009","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.contraception.2010.08.009_bb0160","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1363\/3501603","article-title":"The accessibility of abortion services in the United States, 2001","volume":"35","author":"Henshaw","year":"2003","journal-title":"Perspect Sex Reprod Health"},{"key":"10.1016\/j.contraception.2010.08.009_bb0165","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.whi.2005.07.006","article-title":"Patient costs for medication abortion: results from a study of five clinical practices","volume":"16","author":"Van Bebber","year":"2006","journal-title":"Womens Health Issues"}],"container-title":["Contraception"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010782410004725?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010782410004725?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T22:44:00Z","timestamp":1761432240000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0010782410004725"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,4]]},"references-count":30,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2011,4]]}},"alternative-id":["S0010782410004725"],"URL":"https:\/\/doi.org\/10.1016\/j.contraception.2010.08.009","relation":{},"ISSN":["0010-7824"],"issn-type":[{"value":"0010-7824","type":"print"}],"subject":[],"published":{"date-parts":[[2011,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Introduction and provision of medical abortion: a tale of two countries in which technology is necessary but not sufficient","name":"articletitle","label":"Article Title"},{"value":"Contraception","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.contraception.2010.08.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}